Skip to main content
春光智能 logo

春光智能 — Investor Relations & Filings

Ticker · 920810 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 329 across all filing types
Latest filing 2023-04-23 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920810

About 春光智能

http://www.lncgjx.com/

Chunguang Intelligent specializes in the research, development, and manufacturing of high-performance components for cleaning appliances. The company primarily focuses on flexible hoses, floor brush assemblies, and extension tubes designed for vacuum cleaners and floor scrubbers. By leveraging advanced polymer material technology and integrated production processes, it provides customized solutions to leading global household appliance brands. Its product portfolio includes various hose types such as PVC, EVA, and wire-reinforced structures, emphasizing durability and flexibility. The company maintains a strong focus on technical innovation and quality control to meet the evolving demands of the smart cleaning sector.

Recent filings

Filing Released Lang Actions
2023年一季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as the "2023 First Quarter Report" of 辽宁春光制药装备股份有限公司 (Liaoning Chunguang Pharmaceutical Equipment Co., Ltd.). It contains detailed financial data for the first quarter of 2023, including balance sheet figures, profit and loss data, cash flow statements, explanations of significant changes in financial data, shareholder structure, and disclosures about major events and commitments. The report explicitly states it is a quarterly report and includes comprehensive financial statements and management commentary on the quarter's performance. It is not an announcement of a report publication but the report itself, given the length (15,000 characters) and detailed content. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-04-23 Chinese
关于治理专项自查及规范活动相关情况的报告
Governance Information Classification · 95% confidence The document is a detailed report on the company's governance self-inspection and compliance activities, including internal control, board and management structure, decision-making processes, and related party transactions. It references company law, securities law, and listing rules, and provides extensive information on governance mechanisms and compliance status for the year 2022. The content focuses on governance practices and internal controls rather than financial results or audit opinions. It is not an announcement of a report but the report itself, given the length and detail. Therefore, it fits the category of Governance Information (CGR).
2023-04-23 Chinese
2022年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2022年度募集资金存放与实际使用情况的专项报告" which translates to "2022 Annual Special Report on the Deposit and Actual Use of Raised Funds." It details the amount of funds raised through a public stock issuance, the timing of fund receipt, usage, balance, management, and compliance with regulatory requirements. It includes detailed financial figures related to the raised capital, its allocation, and usage progress. The document also contains verification and audit opinions from accounting firms and sponsors, confirming compliance with relevant securities regulations. The content focuses specifically on the management and use of capital raised from investors, rather than a general financial report or earnings release. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is 4124 characters, which is sufficient to be the report itself rather than a mere announcement. Therefore, the correct classification is CAP with high confidence.
2023-04-23 Chinese
2022年年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as the "2022 Annual Independent Directors' Report" of Liaoning Chunguang Pharmaceutical Equipment Co., Ltd. It details the independent directors' activities, attendance at board and shareholder meetings, opinions on various company matters including financial reports and governance, and their efforts to protect shareholder interests. The content focuses on the independent directors' duties and their report on their work during the year 2022. This type of document is a report by the board members (independent directors) about their management and oversight activities, which fits the category of Board/Management Information (MANG). The document is not a full annual report, audit report, or financial statement, but a specific report on board members' activities and opinions.
2023-04-23 Chinese
2022年年度权益分派预案公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an announcement regarding the 2022 annual profit distribution plan (权益分派预案公告) by 辽宁春光制药装备股份有限公司. It details the proposed dividend payout, conditions, and policies related to profit distribution, including board and supervisory committee approvals, independent director opinions, and references to the company's articles of association. The document is an announcement of a dividend distribution plan to be approved by the shareholders' meeting, not the actual dividend payment notice or the full annual report. It is not a full financial report but a specific announcement about dividend distribution plans and related governance. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and details for shareholders.
2023-04-23 Chinese
控股股东及其他关联方资金占用情况的专项说明
Regulatory Filings
2023-04-23 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.